Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunnya Zarif

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New Zealand Medical Journal|September 17, 2014
Medical image. SchizencephalySunnya Zarif, Hala Alsafadi
Molecular Diagnosis & Therapy|March 30, 2016
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate CancerVincenza Conteduca, Simon J Crabb, Emanuela Scarpi, et al.
Plos One|July 20, 2016
Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate CancerVincenza Conteduca, Simon J Crabb, Robert J Jones, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New Zealand Medical Journal|September 17, 2014
Medical image. SchizencephalySunnya Zarif, Hala Alsafadi
Molecular Diagnosis & Therapy|March 30, 2016
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate CancerVincenza Conteduca, Simon J Crabb, Emanuela Scarpi, et al.
Plos One|July 20, 2016
Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate CancerVincenza Conteduca, Simon J Crabb, Robert J Jones, et al.
Pageof 1